Medical Therapy Induced Regression of Plaque in a Female Patient with ASCVD

Area of Science:

• Cardiology
• Vascular Medicine
• Clinical Case Study

Background:

• Atherosclerotic cardiovascular disease (ASCVD) is typically linked to well-established risk factors.
• Limited literature exists on ASCVD management in patients lacking these conventional risk factors.
• Statin therapy is a cornerstone in ASCVD treatment, supported by extensive clinical trial data.

Observation:

• A 58-year-old woman presented with ASCVD but had no identifiable evidence-based risk factors.
• The patient experienced severe chest pain, indicative of significant cardiovascular compromise.

Findings:

• After a four-year intervention period, including atorvastatin treatment, the patient achieved complete resolution of chest pain.
• Significant regression of atherosclerotic plaques within the coronary arteries was observed.
• This case highlights the potential for ASCVD to develop and progress in the absence of typical risk indicators.

Implications:

• This case underscores the importance of considering ASCVD even in individuals without traditional risk factors.
• It suggests that statin therapy, such as atorvastatin, can be effective in managing ASCVD and promoting plaque regression, irrespective of baseline risk factor status.
• Further research may be warranted to explore the underlying mechanisms of ASCVD in low-risk populations and optimize treatment strategies.